Targeted Forceps Biopsy for Colorectal Tumors

Concordance Rate of Pathology Between Targeted Forceps Biopsy and Resected Specimen for Large Colorectal Tumors

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03604237

Enrollment

Registered

2018-07-27

Start date

2017-09-01

Completion date

2018-10-01

Last updated

2018-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Neoplasms

Keywords

forceps biopsy, colorectal tumors

Brief summary

This study evaluates whether targeted forceps biopsy with careful tumor surface evaluation can improve diagnostic accuracy of colorectal tumors larger than 2 cm during colonoscopy.

Interventions

DIAGNOSTIC_TESTTargeted group

Forceps biopsy is taken after surface evaluation of the large colorectal tumors.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

DIAGNOSTIC

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

19 Years to 85 Years

Healthy volunteers

Inclusion criteria

* Patients with colorectal neoplasms of the size larger than 2 cm

Exclusion criteria

* Patients who deny the participation in the study

Design outcomes

Primary

Measure	Time frame	Description
pathologic diagnosis	7 days	The pathologic diagnosis of forceps biopsy is compared with the pathologic diagnosis of resected specimen of the colorectal tumor.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026